By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company CVS Group plc

CVS Group plc (CVSGF)

OTC Market Data in USD, Fundamentals in GBP
$17.40
$0.00
0.00%
Last Update: 16 Jul 2025, 20:00
$1.25B
Market Cap
0.00
P/E Ratio (TTM)
0.46%
Forward Dividend Yield
$10.20 - $17.40
52 Week Range

CVSGF Stock Price Chart

Explore CVS Group plc interactive price chart. Choose custom timeframes to analyze CVSGF price movements and trends.

There is nothing to show.

CVSGF Company Profile

Discover essential business fundamentals and corporate details for CVS Group plc (CVSGF) to support your stock research and investment decisions.

Sector

Consumer Cyclical

Industry

Personal Products & Services

IPO Date

23 Mar 2018

Employees

9.00K

CEO

Richard William Mark Fairman

Description

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns 472 veterinary practices, 3 laboratories, and 7 crematoria in the United Kingdom, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.

CVSGF Financial Timeline

Browse a chronological timeline of CVS Group plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 Feb 2026

Upcoming earnings on 25 Sept 2025

Earnings released on 26 Feb 2025

EPS came in at $0.20 falling short of the estimated $0.51 by -61.86%, while revenue for the quarter reached $427.64M, beating expectations by +0.36%.

Dividend declared on 31 Oct 2024

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 29 Nov 2024.

Earnings released on 26 Sept 2024

EPS came in at $0.14 falling short of the estimated $0.54 by -74.32%.

Earnings released on 19 Mar 2024

EPS came in at $0.26 falling short of the estimated $0.60 by -56.92%, while revenue for the quarter reached $416.99M, missing expectations by -0.71%.

Dividend declared on 2 Nov 2023

A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 8 Dec 2023.

Earnings released on 30 Jun 2023

EPS came in at $0.37, while revenue for the quarter reached $395.09M.

Earnings released on 31 Dec 2022

EPS came in at $0.36, while revenue for the quarter reached $364.17M, beating expectations by +1.63%.

Dividend declared on 17 Nov 2022

A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 2 Dec 2022.

Earnings released on 30 Jun 2022

EPS came in at $0.14, while revenue for the quarter reached $340.49M.

Earnings released on 31 Dec 2021

EPS came in at $0.33, while revenue for the quarter reached $369.20M, missing expectations by -0.21%.

Dividend declared on 18 Nov 2021

A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 3 Dec 2021.

Earnings released on 30 Jun 2021

EPS came in at $0.15 falling short of the estimated $0.50 by -69.33%, while revenue for the quarter reached $365.47M, missing expectations by -1.72%.

Earnings released on 31 Dec 2020

EPS came in at $0.22 falling short of the estimated $0.40 by -45.70%, while revenue for the quarter reached $334.08M, missing expectations by -0.49%.

CVSGF Stock Performance

Access detailed CVSGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
CVSGF
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
CVSGF
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More